Concepedia

Publication | Open Access

BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes

DOIFull Paper Access

20

Citations

41

References

2020

Year

Lukas Peiffer, Farnoush Farahpour, Ashwin Sriram, Ivelina Spassova, Daniel Hoffmann, Linda Kubat, Patrizia Stoitzner, Thilo Gambichler, Antje Sucker, Selma Ugurel,
Cancer Immunology Immunotherapy

Abstract

Our results suggest that BRAF/MEK inhibition in melanoma patients allows an increased expansion of pre-existing melanoma-specific T cells by induction of T-bet and TCF7 in these.

References

YearCitations

Page 1